Guernsey: The Strongest Link

Last Updated: 19 July 2010
Article by Martin Le Pelley

Most Read Contributor in Guernsey, September 2018

This article was originally published in Captive Review, July 2010

Martin Le Pelley from Heritage Insurance Management looks at how the successful process of amalgamating two Guernsey PCCs gives an indication of how valuable the PCC vehicle may prove following a significant regulatory change such as Solvency II.

In March of this year, Friary Court Insurance PCC (Friary Court), the ex-Heath Lambert-owned cell captive facility which was acquired by Heritage Group as part of the acquisition of Heath Lambert's captive management operations, was amalgamated with Heritage's Harlequin Insurance PCC (Harlequin). This was the first time two protected cell companies (PCCs) have merged.

PCCs versus ICCs

The fundamental difference between a PCC and an incorporated cell company (ICC) is that a PCC, including its cells, is a single legal entity, whilst an ICC and its cells are separate legal entities. An insurance PCC has a single board of directors which take responsibility for the transactions within the core and each of the cells and for the statutory and regulatory compliance and corporate governance requirements of the company as a whole.

The cells are created by the issuance of non-voting redeemable shares which means that the cell shareholders have very limited 'control' over the transactions within the cell. The cell shares are non-voting because the cell shareholders have no statutory right to appoint directors or manage the affairs of the cell, and therefore the shares simply determine ownership of the cellular assets.

In contrast, because ICC cells are separate legal entities, the cell shares might be non-voting, but the cell owner does 'control' the cell because the directors of the ICC have no power to enter into transactions on behalf of the cell.

Ironically, the directors of an incorporated cell of an ICC must, in normal circumstances under Guernsey Law, be the same individuals as the directors of the ICC core. However, they hold two directorships – one for the ICC core, and one for the incorporated cell. Furthermore, as a result of the cell being a separate company, the cell is a controlled foreign company (CFC) for tax purposes. As a result, there is very little difference between the statutory and tax position of an incorporated cell versus a non-cellular company.

Some people believe that the ICC cell structure may offer a more secure environment for the segregation of assets and liabilities than the PCC cell structure, by virtue of it being a separate legal entity. In practice, most PCC cells are managed in isolation from the other cells with separate bank accounts, ledgers and agreements such that there is very little additional risk posed by the lack of separate legal personality.

Economies of scale

As a PCC is a single legal entity there are benefits to be gained from growing the company through the addition of cells, especially where the PCC is used to host third-party captive business. The tax advantages to PCCs are already well known: a cell within a PCC can avoid CFC status where the cell's participation in the profits of the company as a whole are below 25%, and there is no other 'control' over the activities of the cell. This is one key advantage for cell owners as tax on cell profits can be deferred until distributed as a dividend and therefore the lack of control is a benefit. As CFC rules change and the profit participation percentage reduces the larger the PCC, the more likely that any one individual cell will not exceed the threshold, as compared to a smaller PCC.

The economies of scale and reduced administrative burden per cell associated with a large PCC are derived from the PCC structure itself. Because it is a single legal entity the PCC requires only one board meeting for the company as a whole and the directors of the PCC have a corporate governance responsibility for the transactions relating to the PCC as a whole (as compared to an ICC and its cells, where the corporate governance is at a cellular level as each cell is a separate legal entity).


The amalgamation of Friary Court and Harlequin was carried out in accordance with the provisions in Guernsey's 2008 Company Law, which is a modern piece of legislation. This helped to ensure that the process was, to some extent, smoother than might have been the case under older legislation. However, each company's Articles of Association, which were drafted under the previous Company Law, carried equal weight and could not be avoided.

Both Articles of Association carried a somewhat standard 'variation of rights' clause for cellular shareholders such that an amalgamation would be deemed to be a variation of cellular shareholder rights. Normally cellular shares are non-voting preference shares, but under the Articles (which were drafted under the provisions of the 1994 Company Law), if the cell shareholder's rights are varied, the cell shareholders become entitled to approve or vote down the variation. In the case of the above amalgamation, it could be argued that the cellular shareholder rights were varied to their benefit. However, this does not remove the necessity to allow the cell shareholders the right to approve the variation.

Consequently for the purposes of this amalgamation, we required approval by each class of cell share (in other words, each cell owner) in order for the amalgamation to proceed. Under the new Company Law, the variation of cell shareholder rights need not be included in the Articles of Incorporation (as opposed to Association), thus avoiding this rather onerous requirement. For an ICC amalgamation, the cells would still need to approve such a move, regardless of each cell's Articles, as each cell is a separate legal entity.

Of course, obtaining cellular shareholder approval was not the only obstacle. There are legal obligations to produce statutory documentation (such as the Amalgamation Proposal), certify solvency, notify creditors, obtain approval of the regulator (in this case the GFSC) and to meet the requirements of the Company Registry. However, these provisions are all appropriate for the protection of creditors and cell owners and none of these should be problematic in a well-run PCC.

Safeguarding assets

If cell shareholders no longer have the right to vote at all (as a result of the removal of the variation of rights clause from the Articles and no similar provision being included in the law) this could give greater power to the voting shareholders and the directors to carry out such amalgamations or restructuring in the future. This prompts the question as to whether the lack of cell shareholder rights in a PCC causes a risk in relation to the safeguarding of cell assets and, if so, does this mean that an ICC structure is more appropriate?

It is fair to say that an ICC cell, being a separate company, has a very clear separation of assets and liabilities between itself and any other cell of the same or another ICC. However, the safeguarding of assets in a PCC is not compromised by any restructuring or amalgamation that may take place, as the cellular assets are legally ring-fenced and continue to be so before and after any such restructuring.

The biggest issue faced by PCCs in terms of the safeguarding of assets is the risk that any cellular assets held outside of the PCC's home jurisdiction, such as a bank account in an overseas territory, may not be recognised by a foreign court as being a cellular asset because the foreign court does not recognise PCC legislation.

This is a weakness not of the PCC legislation itself, but of the ability of foreign jurisdictions to recognise how the legislation works. The solution to this problem is to ensure that PCC cellular assets are only located in jurisdictions which do recognise PCC legislation. Luckily the list of such jurisdictions is growing all the time.

This 'weakness' in respect of the application of PCC legislation could equally apply to ICCs, although the likelihood is much reduced as almost all countries recognise the legal separation of companies as separate legal personalities.

But how are PCC cell owners protected from, for instance, a restructuring which reduces their cell's economic or fiscal effectiveness? The answer is that the cell owners remain a creditor of the company (by virtue of their shareholding) and would continue to have the right to be notified, and object to, any changes in the structure of the PCC, such that while they may not vote on a change, their views will still be taken into consideration.

It is currently not possible for cells to 'move' from one PCC to another (unlike ICC cells) without Royal Court approval, and this is, in itself, a significant protection for cell owners against being trapped in an uneconomic PCC structure.

In Guernsey, as insurance PCCs are regulated at a cellular level, the regulator will not permit any restructuring which would have a detrimental impact on the solvency or prudent management of the cells within a PCC. Therefore the requirement to seek regulatory approval for any such restructuring brings with it an additional level of protection for cell owners who may be concerned about the proposals.

While the regulations provide significant protection for cell owners' business within the cell, there are also notable advantages for PCC companies in terms of the regulatory approach adopted for PCCs in most domiciles.

As PCCs are single legal entities, the cells are treated as part of the whole PCC for statutory solvency purposes. This is because of the lack of control which cell owners have over the transactions in the cell. From a corporate governance perspective the board of the PCC has responsibility to ensure that the company as a whole meets minimum capital and regulatory requirements.

The cell owners may, however, have some ability to influence the activities within the cell through the management agreement entered into between the cell owners, the PCC and the insurance manager – consequently each PCC's and cell's tax and regulatory status must be considered on a case-by-case basis.

Nevertheless, if the cell is structured such that the level of influence is minimal and the board of the PCC have transparent responsibility for the activities of the company and cells as a whole, then this could have significant implications for the application of regulations such as the forthcoming Solvency II Directive – and could mean that cell captives are able to achieve a level of capital efficiency and regulatory compliance which standalone captives or ICC cells will struggle to achieve.

Better things to come?

It is interesting to note that neither CEIOPS nor the European Commission have mentioned PCCs once within their deliberations on the application of Solvency II. This means that those EEA jurisdictions with PCC legislation may well have a significant degree of freedom to apply the directive and the binding technical standards coming out of CEIOPS Level 2 implementing measures in such a way as to make the PCC a very attractive vehicle for captive insurance business in Europe.

Even if the standard formula is applied at a cellular level within a PCC (due to the ring-fencing of assets and liabilities) such that there isn't a diversification benefit, it may be that an internal model for the PCC as a whole would seem to be more cost-efficient than applying separate models for each cell, and finally, the corporate governance requirements of Solvency II for a PCC, having a single board of directors, may be more easily achieved than would be the case if applied at a cellular level.

Given the concerns that ECIROA, FERMA and others have expressed over the very limited proportionality being afforded to standalone captive insurance companies under Solvency II, it is surprising that these organisations appear to have overlooked the potential benefits which may be achieved by using PCC cells as captive insurers rather than standalone companies or ICCs.

The test of time

ICCs, although a more recent innovation, lack some of the unique benefits which PCCs can bring, such as the ability to manage tax liabilities in an efficient way and to benefit from reduced administrative and corporate governance overhead costs. Whilst some might question the robustness of PCCs in terms of segregation of assets and the cell owner's ability to control the activities in the cell, these risks are more due to a lack of understanding of the legislation as opposed to any weakness in the legislation itself.

PCCs have stood the test of time and are more popular than ever. As the EU introduces a radical new regulatory regime in the form of Solvency II, there are indications that the PCC may be best-placed for captive owners to manage their self-insurance needs in a more cost effective way within Europe.

For more information about Guernsey's finance industry please visit

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions